Kraus Carl N — SEC Form 4 filings

SEC reporting owner CIK 1946475. 5 Form 4 filings on record with FilingPulse; latest filed 2025-10-17.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-03-11 to 2025-10-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Aquestive Therapeutics, Inc. (AQST)Chief Medical Officer51 leg · 20,272 sh · $141,9047

Form 4 filings — Kraus Carl N

FiledFormIssuerReported transactionsSource
2025-10-174Aquestive Therapeutics, Inc. (AQST)Sale (S): 20,272 @ $7EDGAR
2025-08-124Aquestive Therapeutics, Inc. (AQST)Tax withholding (F): 10,819 @ $3.90EDGAR
2025-03-114Aquestive Therapeutics, Inc. (AQST)Grant/award (A): 70,000 @ $0 · Tax withholding (F): 8,115 @ $2.65 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-08-124Aquestive Therapeutics, Inc. (AQST)Tax withholding (F): 10,819 @ $3.43EDGAR
2024-03-114Aquestive Therapeutics, Inc. (AQST)Grant/award (A): 112,500 @ $0 · Grant/award (A): 56,250 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1946475 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →